1. Home
  2. RDY vs ELS Comparison

RDY vs ELS Comparison

Compare RDY & ELS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDY
  • ELS
  • Stock Information
  • Founded
  • RDY 1984
  • ELS 1992
  • Country
  • RDY India
  • ELS United States
  • Employees
  • RDY N/A
  • ELS N/A
  • Industry
  • RDY Biotechnology: Pharmaceutical Preparations
  • ELS Real Estate Investment Trusts
  • Sector
  • RDY Health Care
  • ELS Real Estate
  • Exchange
  • RDY Nasdaq
  • ELS Nasdaq
  • Market Cap
  • RDY 13.1B
  • ELS 13.9B
  • IPO Year
  • RDY N/A
  • ELS 1993
  • Fundamental
  • Price
  • RDY $79.49
  • ELS $68.69
  • Analyst Decision
  • RDY Buy
  • ELS Buy
  • Analyst Count
  • RDY 1
  • ELS 8
  • Target Price
  • RDY $87.00
  • ELS $73.50
  • AVG Volume (30 Days)
  • RDY 156.2K
  • ELS 1.3M
  • Earning Date
  • RDY 10-29-2024
  • ELS 10-21-2024
  • Dividend Yield
  • RDY 1.20%
  • ELS 2.77%
  • EPS Growth
  • RDY 17.48
  • ELS 22.74
  • EPS
  • RDY 4.00
  • ELS 1.95
  • Revenue
  • RDY $3,460,984,788.00
  • ELS $1,516,784,000.00
  • Revenue This Year
  • RDY $13.21
  • ELS N/A
  • Revenue Next Year
  • RDY $8.56
  • ELS $4.10
  • P/E Ratio
  • RDY $19.79
  • ELS $35.36
  • Revenue Growth
  • RDY 10.49
  • ELS 3.04
  • 52 Week Low
  • RDY $63.72
  • ELS $59.82
  • 52 Week High
  • RDY $84.46
  • ELS $76.60
  • Technical
  • Relative Strength Index (RSI)
  • RDY 46.19
  • ELS 44.48
  • Support Level
  • RDY $78.40
  • ELS $65.32
  • Resistance Level
  • RDY $80.00
  • ELS $70.72
  • Average True Range (ATR)
  • RDY 0.86
  • ELS 1.36
  • MACD
  • RDY 0.11
  • ELS 0.12
  • Stochastic Oscillator
  • RDY 58.28
  • ELS 62.41

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

About ELS Equity Lifestyle Properties Inc.

Equity Lifestyle Properties is a residential REIT that focuses on owning manufactured housing, residential vehicle communities, and marinas. The company currently has a portfolio of 451 properties across the U.S. with a higher concentration in the Sunbelt region with 38% of the company's properties located in Florida, 12% in Arizona, and 8% in California. Equity Lifestyle targets owning properties in attractive retirement destinations with over 70% of the company's properties either being age-restricted or having an average resident age over 55.

Share on Social Networks: